Filing Details
- Accession Number:
- 0001437749-20-024126
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-18 08:33:33
- Reporting Period:
- 2020-11-16
- Accepted Time:
- 2020-11-18 08:33:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1053691 | Diffusion Pharmaceuticals Inc. | DFFN | Pharmaceutical Preparations (2834) | 300645032 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1828068 | Robert William Elder | 1317 Carlton Avenue, Suite 200 Charlottesville VA 22902 | Gc & Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-16 | 10,000 | $0.67 | 10,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-11-17 | 5,000 | $0.63 | 15,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The price reported is a weighted average price. The shares were purchased in multiple open-market transactions at prices ranging from $0.6492 to $0.6890, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares sold at each separate price within such range.
- The price reported is a weighted average price. The shares were purchased in multiple open-market transactions at prices ranging from $0.6234 to $0.6298, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares sold at each separate price within such range.
Billionaire Hedge Funds
